Post

UPDATE: The FDA has issued an update on its long-awaited safety review of the abortion drug mifepristone. Louisiana AG Liz Murrill has sued the FDA to undo policy that allows prescriptions of the drug through telehealth appointments. @sofiaresnick.bsky.social reports for @statesnewsroom.com

lailluminator.comFDA provides update on abortion pill review for Louisiana telehealth case • Louisiana IlluminatorThe U.S. Food and Drug Administration said late Wednesday that it expects to complete its long-awaited safety review of abortion pills by mid-December and issue a report evaluating the results by Marc...

1 repost0 likes

No replies yet.